Cargando...
Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice
OBJECTIVE: Over a third of all patients with epilepsy are refractory to treatment and there is an urgent need to develop new drugs that can prevent the development and progression of epilepsy. Epileptogenesis is characterized by distinct histopathological and biochemical changes, which include astro...
Gardado en:
| Publicado en: | Epilepsia |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6713278/ https://ncbi.nlm.nih.gov/pubmed/30815855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.14674 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|